ATHE
Price
$4.54
Change
-$0.06 (-1.30%)
Updated
Oct 24 closing price
Capitalization
85.02M
Intraday Buy/Sell Signals
QNTM
Price
$13.90
Change
-$0.54 (-3.74%)
Updated
Oct 24 closing price
Capitalization
53.15M
Intraday Buy/Sell Signals
Interact to see
Advertisement

ATHE vs QNTM

Header iconATHE vs QNTM Comparison
Open Charts ATHE vs QNTMBanner chart's image
Alterity Therapeutics
Price$4.54
Change-$0.06 (-1.30%)
Volume$14.88K
Capitalization85.02M
Quantum Biopharma
Price$13.90
Change-$0.54 (-3.74%)
Volume$83.64K
Capitalization53.15M
ATHE vs QNTM Comparison Chart in %
ATHE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QNTM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ATHE vs. QNTM commentary
Oct 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATHE is a Hold and QNTM is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 27, 2025
Stock price -- (ATHE: $4.54 vs. QNTM: $13.90)
Brand notoriety: ATHE and QNTM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATHE: 13% vs. QNTM: 71%
Market capitalization -- ATHE: $85.02M vs. QNTM: $53.15M
ATHE [@Biotechnology] is valued at $85.02M. QNTM’s [@Biotechnology] market capitalization is $53.15M. The market cap for tickers in the [@Biotechnology] industry ranges from $108.04B to $0. The average market capitalization across the [@Biotechnology] industry is $2.04B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATHE’s FA Score shows that 0 FA rating(s) are green whileQNTM’s FA Score has 0 green FA rating(s).

  • ATHE’s FA Score: 0 green, 5 red.
  • QNTM’s FA Score: 0 green, 5 red.
According to our system of comparison, QNTM is a better buy in the long-term than ATHE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATHE’s TA Score shows that 5 TA indicator(s) are bullish while QNTM’s TA Score has 3 bullish TA indicator(s).

  • ATHE’s TA Score: 5 bullish, 5 bearish.
  • QNTM’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, ATHE is a better buy in the short-term than QNTM.

Price Growth

ATHE (@Biotechnology) experienced а -7.16% price change this week, while QNTM (@Biotechnology) price change was -1.84% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.97%. For the same industry, the average monthly price growth was +11.13%, and the average quarterly price growth was +63.98%.

Industries' Descriptions

@Biotechnology (+0.97% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ATHE($85M) has a higher market cap than QNTM($53.2M). QNTM YTD gains are higher at: 277.717 vs. ATHE (37.160). ATHE has higher annual earnings (EBITDA): -12.19M vs. QNTM (-26.86M). ATHE has more cash in the bank: 40.7M vs. QNTM (1.53M). ATHE has less debt than QNTM: ATHE (155K) vs QNTM (2.27M). ATHE (0) and QNTM (0) have equivalent revenues.
ATHEQNTMATHE / QNTM
Capitalization85M53.2M160%
EBITDA-12.19M-26.86M45%
Gain YTD37.160277.71713%
P/E RatioN/AN/A-
Revenue00-
Total Cash40.7M1.53M2,664%
Total Debt155K2.27M7%
FUNDAMENTALS RATINGS
ATHE vs QNTM: Fundamental Ratings
ATHE
QNTM
OUTLOOK RATING
1..100
5015
VALUATION
overvalued / fair valued / undervalued
1..100
83
Overvalued
63
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
3944
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
9050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

QNTM's Valuation (63) in the null industry is in the same range as ATHE (83) in the Biotechnology industry. This means that QNTM’s stock grew similarly to ATHE’s over the last 12 months.

QNTM's Profit vs Risk Rating (100) in the null industry is in the same range as ATHE (100) in the Biotechnology industry. This means that QNTM’s stock grew similarly to ATHE’s over the last 12 months.

QNTM's SMR Rating (100) in the null industry is in the same range as ATHE (100) in the Biotechnology industry. This means that QNTM’s stock grew similarly to ATHE’s over the last 12 months.

ATHE's Price Growth Rating (39) in the Biotechnology industry is in the same range as QNTM (44) in the null industry. This means that ATHE’s stock grew similarly to QNTM’s over the last 12 months.

ATHE's P/E Growth Rating (100) in the Biotechnology industry is in the same range as QNTM (100) in the null industry. This means that ATHE’s stock grew similarly to QNTM’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ATHEQNTM
RSI
ODDS (%)
Bullish Trend 3 days ago
84%
N/A
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
82%
Momentum
ODDS (%)
Bullish Trend 3 days ago
77%
Bearish Trend 3 days ago
88%
MACD
ODDS (%)
Bullish Trend 3 days ago
81%
Bearish Trend 3 days ago
80%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
87%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
73%
Bearish Trend 3 days ago
87%
Advances
ODDS (%)
Bullish Trend 12 days ago
71%
Bullish Trend 6 days ago
85%
Declines
ODDS (%)
Bearish Trend 5 days ago
89%
Bearish Trend 10 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
79%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
ATHE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QNTM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CFNCF367.43N/A
N/A
Cie Financiere Tradition Lausanne ACT
CVPUF1.30N/A
N/A
C.P. All Public Co Ltd
TEKCF0.13N/A
N/A
Tekcapital plc
CCCP0.05N/A
N/A
Crona Corp.
EDTXF1.12-0.01
-0.88%
Spectral Medical Inc.

QNTM and

Correlation & Price change

A.I.dvisor indicates that over the last year, QNTM has been loosely correlated with HYPD. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if QNTM jumps, then HYPD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To QNTM
1D Price
Change %
QNTM100%
-3.74%
HYPD - QNTM
34%
Loosely correlated
-4.21%
ATHE - QNTM
27%
Poorly correlated
-1.30%
CPIX - QNTM
26%
Poorly correlated
-0.57%
EBS - QNTM
24%
Poorly correlated
+0.83%
PBH - QNTM
24%
Poorly correlated
-0.58%
More